BU-NOT-SET

CONTACT US
Advanced Bio is advancing rAAV production
  • Biologics
  • Manufacturing
Recipharm_Advanced_Bio_Virus
White paper
Advanced Bio Is advancing LNP formulation
  • Biologics
  • Manufacturing
Recipharm_AdvancedBio_RNA
White paper
Optimising drug formulation: The critical role of granulation
  • Drug product
  • Manufacturing
powder
White paper
Overcoming fixed-dose combination challenges for ALS
  • Drug product
  • Manufacturing
Recipharm_API
Case study
What’s shaping the future of pharma?
  • Industry trends
Vials
Video
Mastering tech-transfer: Turning complexity into competitive advantage
  • Drug product
  • Manufacturing
ReciPredict_people in a z
Insight
Four ways ReciPredict can transform your pharma manufacturing
  • Drug product
  • Manufacturing
logo
Insight
An expert’s guide to analytical services
  • Analytical chemistry
  • Industry trends
people in a lab
Insight
How lyophilisation can help overcome mRNA stability challenges
  • Drug product
  • Manufacturing
jars
Insight
Insight
  • Industry trends
The potential impact of Brexit on patient safety
Insight
  • Manufacturing
EU FMD: After the deadline
Insight
  • Manufacturing
The importance of supply chain security
Insight
  • Drug substance
ADC development: setbacks and key developments
Insight
  • Drug substance
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Insight
  • Industry trends
CDMO trends: Drug development and industry consolidation
Insight
  • Industry trends
Consolidation in the CDMO Market
Insight
  • Industry trends
The benefits of outsourcing to CDMOs
Insight
  • Manufacturing
Falsified Medicines Directive and the future of serialisation